External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

2021 GU Cancers Symposium

-
Coming soon
03:46 PM
Duration 5mins Virtual
PI3K/AKT pathway biomarkers analysis of the Phase III IPATential150 trial of ipatasertib plus abiraterone in metastatic castration-resistant prostate cancer

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar